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INTRODUCTION
Magnetic resonance imaging (MRI) is rarely 
used as an investigation in clinical psychi-
atric practice. The reasons for this are sev-
eral, and include the cultural viewpoint of 
 psychiatry as a psychosocial specialty as well 
as particular concerns about the experience 
of brain imaging amongst patients and cli-
nicians. Where MRI is used it is to exclude 
neurological disorders in those presenting 
with mental illness. However the yield of 
such disorders through MRI screening not 
detected through other clinical examination 
in ‘typical’ presentations of mental illness is 
very low, and routine MRI is not currently 
recommended for those with mental ill-
ness without warning signs of neurologi-
cal disorder. However functional imaging 
does have clinical potential, with the pos-
sibility for assisting both with diagnosis and 
treatment planning, and this potential will 
be discussed.
CULTURAL SHIFT IN THE VIEW OF 
PSYCHIATRY
Psychiatry was originally described by Reil 
(1808) as a purely medical speciality that 
should be undertaken by only the best phy-
sicians, and into which philosophers and 
psychologists should not be incorporated. 
The specialty included the management of 
all disorders of the ‘soul’, including both 
mind and brain (Marneros, 2008).
Psychiatry as practiced today has evolved 
into a community based holistic specialty 
where psychosocial models of illness sit 
alongside biological perspectives, and 
patients are managed using a broad range 
of these approaches (Craddock et al., 2008). 
This practice has developed due to the lack 
of established ‘organicity’ of psychiatric 
illness and the prominence of psychologi-
cal theorists in the 20th century. There is 
therefore currently an arbitrary division 
of brain disorders into the specialties of 
psychiatry and neurology, with different 
terminologies for the same phenomena, 
and different   clinical practices. This has 
been to the detriment of patients on both 
sides of the divide. In practical terms this 
manifests itself with the ease of access to 
MRI on the neurological side, including an 
expectation from patients that this should 
be offered. The use of MRI is rare in psy-
chiatric practice, however, both because of 
the psychosocial interpretation of symp-
toms amongst clinicians and patients, and 
the dispersed nature of the clinical practice. 
To incorporate functional magnetic reso-
nance imaging (fMRI) scans into routine 
psychiatric practice, if this was shown to be 
useful, would therefore require a signiﬁ  cant 
culture change. However there are clinical 
presentations that should include imaging 
as part of routine care. These include late 
onset ﬁ  rst episode of mental illness (affec-
tive or psychotic), atypical presentations or 
where there is any other suspicion of neuro-
logical disorder (sensory or motor or cranial 
nerve disturbance, ﬁ  ts or loss of conscious-
ness). The use of MRI and perfusion hex-
amethylpropyleneamine oxime (HMPAO) 
single-photon emission computed tomog-
raphy (SPECT) in the early differential diag-
nosis of dementia sub-types should also be 
part of routine care. In these cases clinicians 
and patients should expect imaging to be 
part of the normal   assessment protocol.
CLINICAL EXPERIENCE
A further reluctance of clinicians to refer 
patients for MRI scans may be a concern 
about the acceptability of the procedure 
to the patient – that the experience will be 
traumatic and may make people feel worse. 
MRI scanners are noisy and feel enclosed. 
The main cause of distress that people 
describe during MRI scans is claustrophobia. 
Certainly patients who are mentally ill and 
particularly if they have pathological levels 
of anxiety will have an increased chance of 
experiencing claustrophobia whilst in the 
scanner. Some patients who are already 
  feeling vulnerable may feel   traumatized 
by the experience. Furthermore, patients 
who are paranoid may become concerned 
that the scanner can read their mind and 
tell what they are thinking. The high tech 
nature of the investigation and the fact that 
patients are being observed and monitored 
from a separate room can be difﬁ  cult to tol-
erate for patients who are acutely sensitive 
to other people’s intentions towards them.
As well as being unpleasant for some 
patients because of the nature of mental ill-
ness, it may not be possible to achieve high 
quality images in acutely unwell patients 
because of movement. Patients who are 
manic in particular may have difﬁ  culty 
lying still. There would therefore have to be 
a high suspicion of pathology to persist with 
obtaining an MRI in an acutely mentally 
ill patient. There needs to be an individual 
judgement of possible beneﬁ  t with the dis-
tress that may be caused in the patient.
PATIENT EXPERIENCE
In my experience there are both positive 
and negative views of brain imaging from 
patients with mental illness. The positive 
view is that brain imaging may be helpful 
in being able to validate the real nature of 
their experiences. So for instance, the ability 
to demonstrate auditory cortex activation 
during the subjective experience of auditory 
hallucinations shows in an objective way 
that patients really are hearing voices – the 
activation from the hallucination is of the 
same quality as the activation from external 
auditory stimuli (Lennox et al., 2001).
The negative view is that brain imaging 
is a biological and reductionist method of 
looking for abnormality in those with men-
tal illness. Many people with mental illness 
object to having the individual nature of 
their experience reduced to an abnormal 
pattern of brain activation, or a structural 
deﬁ  cit. The implication is that illness is pre-
determined by brain structure and function, 
and that there is little control the individual 
can have over their recovery.Lennox  Clinical opinion fMRI
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Mental illness is a complex interplay 
between both biological and environmental 
factors, and many interesting imaging stud-
ies are now showing both the effect of the 
environment on brain structure and func-
tion, and the plasticity of the brain, both to 
recover after injury and to increase in grey 
matter with training.
CLINICAL POTENTIAL FOR BRAIN 
IMAGING
Changes on structural MRI are seen in all 
the major psychiatric illnesses (schizophre-
nia, bipolar disorder, depression, obsessive 
compulsive disorder). However, these are 
not speciﬁ  c enough to warrant the rou-
tine use of structural MRI to diagnose 
these disorders. However functional brain 
  imaging, currently a research tool, has the 
real   prospect of helping in the diagnosis 
and treatment decisions for patients with 
 mental illness in the near future. As an illus-
tration I will focus on the use of fMRI in the 
diagnosis and treatment planning of those 
with depression.
fMRI OF DEPRESSION
Functional imaging relies on the change 
in blood oxygenation within the brain on 
performing a task, with the assumption 
that blood oxygenation is a proxy meas-
ure for brain activity. The task is used as a 
probe of areas relevant to the disorder being 
investigated. Hence in functional imaging 
of mood disorders, it is common to use 
emotional images, which activate areas 
important in processing emotion and then 
compare activation patterns with healthy 
controls. The areas of brain that increase 
in oxygenation as the images increase in 
intensity of emotion can be assumed to 
be the areas associated with processing of 
that emotion.
fMRI TO PREDICT TREATMENT 
RESPONSE IN DEPRESSION
Using these methods there are reliable 
  patterns of abnormalities shown in the 
emotion processing network in depres-
sion, with underactivity in anterior cingu-
late, and overactivity of the amygdala in 
particular (Drevets et al., 1997). These areas 
are closely interconnected, with a feedback 
loop between the two, and the underactivity 
in cingulate causing consequent overactiv-
ity in amygdala. It appears as though while 
abnormality in both regions is required 
for the clinical syndrome, normalizing the 
abnormality in either region can result in 
treatment improvement. The level of amy-
gdala overactivity has been shown to cor-
relate with severity of illness as measured 
clinically, and is coupled with treatment 
response – normalising with effective treat-
ment with antidepressants and persisting in 
those not responding to treatment (Chen 
et al.,  2008). In contrast, psychological 
treatment has a more ‘top-down’ effect, 
altering prefrontal activation directly rather 
than the amygdalae (Fu et al., 2008).
Functional imaging may therefore be 
helpful in tailoring treatment for those with 
depression – those with the highest level of 
amygdala overactivation being most likely 
to beneﬁ  t from antidepressants, and those 
with predominantly prefrontal underac-
tivation being most likely to beneﬁ  t from 
cognitive behavioural therapy.
fMRI TO DIAGNOSE DEPRESSION
Bipolar disorder and unipolar depression 
are separate disorders with distinct phar-
macological treatments. In those presenting 
with depression without a previous history 
of mania it is not possible to distinguish 
the two disorders on clinical features alone. 
Up to 28% of those with depression will 
progress to having a diagnosis of bipolar dis-
order (Hantouche et al., 1998). Functional 
imaging studies indicate different patterns 
of brain activity in those with bipolar and 
unipolar depression (Savitz and Drevets, 
2009). fMRI could therefore be of diagnos-
tic use in those with depression.
fMRI TO AID DIAGNOSIS IN 
DEPRESSION
fMRI may also be useful in distinguishing 
those with unipolar and bipolar depres-
sion. Each of these disorders has a differ-
ent aetiology and the optimal treatments are 
different. It is difﬁ  cult to separate the two 
in a patient presenting solely with depres-
sive symptoms, without a history of bipo-
lar disorder. Estimates are that as many as 
28% of those presenting with only depres-
sion will go on to develop bipolar disor-
der (Hantouche et  al., 1998). Functional 
imaging studies show distinct patterns of 
activation in the two disorders. Those with 
bipolar disorder show persistent overactiva-
tion in ventromedial prefrontal cortex when 
depressed, compared with underactivation 
in unipolar depression (Savitz and Drevets, 
2009). fMRI could therefore be a   screening 
tool for those with depression, allowing 
optimal treatment to be started early in the 
course of the illness.
The main caveat is that all of these 
results are from studies on carefully selected 
research populations, without the normal 
comorbidities and variability of those 
seen in everyday clinical practice. Further 
  studies are needed to demonstrate the 
generalisability of these promising data. 
Research is also needed to establish the 
cost beneﬁ  t of the introduction of fMRI 
into clinical practice.
CONCLUSION
MRI is rarely used in clinical psychiatric 
practice, with a lack of current evidence that 
it is cost effective in improving diagnosis. 
There are particular reasons why patients 
with mental illness may have difﬁ  culty in 
taking part in MRI studies, and there are 
particular concerns about the implications 
of structural brain differences on individual 
experience of illness. However other patients 
embrace the potential to demonstrate bio-
logical differences to explain the subjective 
experiences of mental illness. Whilst it is dif-
ﬁ  cult to argue the case for routine use of 
structural MRI for those with mental illness 
there are exciting possibilities for the use of 
functional MRI in diagnosing and planning 
treatment for those with depression, such 
that the optimal management of those with 
depression in the near future should include 
the use of fMRI.
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